Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 2, Pages e1082028
Publisher
Informa UK Limited
Online
2015-08-31
DOI
10.1080/2162402x.2015.1082028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c+MHCII+ Macrophages and Dendritic Cells
- (2015) Julie Helft et al. IMMUNITY
- Anti–PD-1 Therapy in Melanoma
- (2015) Blanca Homet Moreno et al. SEMINARS IN ONCOLOGY
- Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
- (2015) Luana Calabrò et al. Lancet Respiratory Medicine
- The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
- (2015) Andrea Khong et al. BMC CANCER
- Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
- (2014) A Linton et al. BRITISH JOURNAL OF CANCER
- Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy
- (2014) Alison M. McDonnell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Is cancer vaccination feasible at older age?
- (2014) Claudia Gravekamp et al. EXPERIMENTAL GERONTOLOGY
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
- (2013) Luana Calabrò et al. LANCET ONCOLOGY
- Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
- (2013) W. Joost Lesterhuis et al. PLoS One
- Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
- (2013) R. Hassan et al. Science Translational Medicine
- Immunity and malignant mesothelioma: From mesothelial cell damage to tumor development and immune response-based therapies
- (2012) Valerio Izzi et al. CANCER LETTERS
- IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
- (2012) Connie Jackaman et al. INTERNATIONAL IMMUNOLOGY
- The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer
- (2012) Andrea Khong et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumor-draining lymph node metastasis
- (2012) Kazuhiro Imai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Age-Related Oxidative Stress Compromises Endosomal Proteostasis
- (2012) Elvira S. Cannizzo et al. Cell Reports
- Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway
- (2010) Celine S. Lages et al. AGING CELL
- Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
- (2010) Vegard Tjomsland et al. BMC CANCER
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
- (2010) S. C. H. Kao et al. CLINICAL CANCER RESEARCH
- CD40-activated B cells contribute to mesothelioma tumor regression
- (2010) Connie Jackaman et al. IMMUNOLOGY AND CELL BIOLOGY
- Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
- (2009) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
- (2009) Oihana Murillo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells
- (2009) C. Jackaman et al. EUROPEAN RESPIRATORY JOURNAL
- Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
- (2009) S. A. Broomfield et al. JOURNAL OF IMMUNOLOGY
- Therapeutic influence on circulating and monocyte-derived dendritic cells in laryngeal squamous cell carcinoma patients
- (2008) Xiao Jie Ma et al. ACTA OTO-LARYNGOLOGICA
- CD1a expression defines an interleukin-12 producing population of human dendritic cells
- (2008) M. Cernadas et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
- (2008) H. van Cruijsen et al. CLINICAL CANCER RESEARCH
- Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
- (2008) Connie Jackaman et al. INTERNATIONAL IMMUNOLOGY
- Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy
- (2008) Simon J. Harrison et al. LEUKEMIA & LYMPHOMA
- Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling
- (2008) Scott H Robbins et al. GENOME BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started